How to Buy Amrutanjan Health Care Ltd Shares?
You can easily buy the stocks/shares of Amrutanjan Health Care Ltd (AMRUTANJAN) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Amrutanjan Health Care Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of AMRUTANJAN as on 15th May 2025 is ₹716.66What is the return on Amrutanjan Health Care Ltd share?
The past returns of Amrutanjan Health Care Ltd (AMRUTANJAN) share are- Past 1 week: N/A
- Past 1 month: -76.62
- Past 3 months: 18.05
- Past 6 months: -7.34
- Past 1 year: -8.09
- Past 3 years: -13.07
- Past 5 years: 78.09
What is the Dividend yield % on Amrutanjan Health Care Ltd share?
The current dividend yield of Amrutanjan Health Care Ltd (AMRUTANJAN) is 0.66What is the Market Cap of Amrutanjan Health Care Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Amrutanjan Health Care Ltd (AMRUTANJAN) is ₹2007.06Cr as of 15th May 2025What is the 52 Week High and Low of Amrutanjan Health Care Ltd?
The 52-week high and low of Amrutanjan Health Care Ltd (AMRUTANJAN) is ₹862.60 and ₹544.10.What is the PE and PB ratio of Amrutanjan Health Care Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Amrutanjan Health Care Ltd are 39.49 and 6.96 respectively.Which sector does Amrutanjan Health Care Ltd belong to?
Amrutanjan Health Care Ltd (AMRUTANJAN) belongs to the Health Care sector & Pharmaceuticals sub-sector.What are the peers or stocks similar to Amrutanjan Health Care Ltd?
The peers or stocks similar to Amrutanjan Health Care Ltd are: and many others.Can't decide whether or not to buy Amrutanjan Health Care Ltd?
Worry no more! Login to Tickertape and check out Amrutanjan Health Care Ltd (AMRUTANJAN) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Amrutanjan Health Care Ltd?
The 52-week high and low of Amrutanjan Health Care Ltd (AMRUTANJAN) is ₹862.60 and ₹544.10.1. Test Stocks FAQ for Amrutanjan Health Care Ltd Shares?
You can easily buy the stocks/shares of Amrutanjan Health Care Ltd (AMRUTANJAN) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Amrutanjan Health Care Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of AMRUTANJAN as on 15th May 2025 is ₹716.66
Amrutanjan Health Care Ltd
AMRUTANJAN Share Price
716.660.18% (+1.26)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
AMRUTANJAN Performance & Key Metrics
AMRUTANJAN Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 39.47 | 6.96 | 0.66% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
AMRUTANJAN Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
AMRUTANJAN Company Profile
Amrutanjan Health Care Limited is engaged in offering ayurvedic balm for headaches, cold and cough. The Company operates through three segments: over-the-counter (OTC) products, beverages and others.
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
89.19
89.19
CIPLA
PE Ratio
23.03
23.03
1Y Return
2.55%
2.55%
Buy Reco %
71.05
71.05
DRREDDY
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
82.05
82.05
TORNTPHARM
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
67.74
67.74
MANKIND
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
—
—
AMRUTANJAN Sentiment Analysis
AMRUTANJAN Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
AMRUTANJAN Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
AMRUTANJAN Stock Growth Drivers
AMRUTANJAN Stock Growth Drivers
2Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
AMRUTANJAN Stock Challenges
AMRUTANJAN Stock Challenges
2Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
AMRUTANJAN Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
AMRUTANJAN Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
AMRUTANJAN
AMRUTANJAN
Income
Balance Sheet
Cash Flow
Annual Normal View
AMRUTANJAN Income Statement
AMRUTANJAN Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 214.14 | 227.88 | 260.36 | 269.80 | 344.16 | 421.22 | 394.18 | 437.58 | 469.50 | 469.49 | ||||||||||
Raw Materials | 85.69 | 94.01 | 122.16 | 124.05 | 135.18 | 185.96 | 183.71 | 209.67 | 393.62 | 393.61 | ||||||||||
| Power & Fuel Cost | 1.66 | 1.70 | 1.87 | 2.02 | 1.76 | 2.66 | 3.06 | 3.84 | ||||||||||||
| Employee Cost | 29.67 | 33.85 | 33.36 | 39.36 | 41.70 | 48.23 | 48.81 | 47.69 | ||||||||||||
| Selling & Administrative Expenses | 54.33 | 53.14 | 59.96 | 61.45 | 64.72 | 84.68 | 86.95 | 89.23 | ||||||||||||
| Operating & Other expenses | 6.69 | 9.10 | 4.95 | 3.77 | 14.64 | 4.74 | 12.57 | 18.89 | ||||||||||||
EBITDA | 36.10 | 36.08 | 38.06 | 39.15 | 86.16 | 94.95 | 59.08 | 68.26 | 75.88 | 75.88 | ||||||||||
| Depreciation/Amortization | 2.05 | 2.91 | 3.16 | 4.36 | 3.67 | 3.80 | 5.21 | 6.06 | 6.53 | 6.52 | ||||||||||
| PBIT | 34.05 | 33.17 | 34.90 | 34.79 | 82.49 | 91.15 | 53.87 | 62.20 | 69.35 | 69.36 | ||||||||||
| Interest & Other Items | 0.25 | 0.31 | 0.20 | 0.34 | 0.59 | 0.58 | 0.22 | 0.25 | 0.22 | 0.22 | ||||||||||
| PBT | 33.80 | 32.86 | 34.70 | 34.45 | 81.90 | 90.57 | 53.65 | 61.95 | 69.13 | 69.14 | ||||||||||
| Taxes & Other Items | 11.99 | 12.91 | 10.17 | 9.37 | 20.71 | 23.39 | 13.81 | 16.97 | 18.30 | 18.29 | ||||||||||
| Net Income | 21.81 | 19.95 | 24.53 | 25.08 | 61.19 | 67.18 | 39.84 | 44.98 | 50.83 | 50.85 | ||||||||||
| EPS | 7.46 | 6.83 | 8.39 | 8.58 | 20.93 | 22.98 | 13.63 | 15.47 | 17.58 | 17.59 | ||||||||||
| DPS | 1.93 | 1.53 | 2.15 | 2.10 | 4.20 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | ||||||||||
| Payout ratio | 0.26 | 0.22 | 0.26 | 0.24 | 0.20 | 0.20 | 0.34 | 0.30 | 0.26 | 0.26 |
AMRUTANJAN Company Updates
FY 2025FY 2025
Investor Presentation
May 19PDF
Nov 13PDF
AMRUTANJAN Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
AMRUTANJAN Past Performance & Peer Comparison
AMRUTANJAN Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Amrutanjan Health Care Ltd | 39.49 | 6.96 | 0.66% |
| Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
| Cipla Ltd | 23.03 | 4.53 | 1.06% |
| Dr Reddy's Laboratories Ltd | 20.02 | 4.01 | 0.59% |
AMRUTANJAN Stock Price Comparison
Compare AMRUTANJAN with any stock or ETFCompare AMRUTANJAN with any stock or ETF
AMRUTANJAN
AMRUTANJAN Holdings
AMRUTANJAN Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
AMRUTANJAN Promoter Holdings Trend
AMRUTANJAN Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
AMRUTANJAN Institutional Holdings Trend
AMRUTANJAN Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
AMRUTANJAN Shareholding Pattern
AMRUTANJAN Shareholding Pattern
AMRUTANJAN Shareholding History
AMRUTANJAN Shareholding History
Foreign Institutions
Mutual Funds Invested in AMRUTANJAN
Mutual Funds Invested in AMRUTANJAN
No mutual funds holding trends are available
Top 3 Mutual Funds holding Amrutanjan Health Care Ltd
| Funds (Top 3) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 5.2930% | Percentage of the fund’s portfolio invested in the stock 0.65% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 57/79 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.5319% | Percentage of the fund’s portfolio invested in the stock 2.51% | Change in the portfolio weight of the stock over the last 3 months 0.13% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/31 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.7224% | Percentage of the fund’s portfolio invested in the stock 1.04% | Change in the portfolio weight of the stock over the last 3 months 1.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 48/84 (-43) |
Compare 3-month MF holding change on Screener
smallcases containing AMRUTANJAN stock
smallcases containing AMRUTANJAN stock
Looks like this stock is not in any smallcase yet.
AMRUTANJAN Events
AMRUTANJAN Events
AMRUTANJAN Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AMRUTANJAN has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.66%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.63 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
AMRUTANJAN Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AMRUTANJAN has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.66%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.63 every year
AMRUTANJAN Upcoming Dividends
AMRUTANJAN Upcoming Dividends
No upcoming dividends are available
AMRUTANJAN Past Dividends
AMRUTANJAN Past Dividends
Cash Dividend
Ex DateEx DateFeb 18, 2025
Interim 2
Interim 2 | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Feb 18, 2025
Cash Dividend
Ex DateEx DateNov 22, 2024
Interim 1
Interim 1 | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 22, 2024
Cash Dividend
Ex DateEx DateSep 13, 2024
Final
Final | Div/Share: ₹2.60
Dividend/Share
₹2.60
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateFeb 19, 2024
Interim 2
Interim 2 | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Feb 19, 2024
Cash Dividend
Ex DateEx DateNov 22, 2023
Interim 1
Interim 1 | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 22, 2023
AMRUTANJAN Stock News & Opinions
AMRUTANJAN Stock News & Opinions
Articles & Videos
Earnings
Amrutanjan Health Care standalone net profit rises 11.13% in the March 2025 quarter
Net profit of Amrutanjan Health Care rose 11.13% to Rs 15.18 crore in the quarter ended March 2025 as against Rs 13.66 crore during the previous quarter ended March 2024. Sales rose 6.57% to Rs 135.41 crore in the quarter ended March 2025 as against Rs 127.06 crore during the previous quarter ended March 2024. For the full year,net profit rose 13.03% to Rs 50.83 crore in the year ended March 2025 as against Rs 44.97 crore during the previous year ended March 2024. Sales rose 7.26% to Rs 451.82 crore in the year ended March 2025 as against Rs 421.23 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales135.41127.06 7 451.82421.23 7 OPM %13.0712.78 -12.8812.30 - PBDT22.4821.14 6 75.6668.00 11 PBT20.8619.61 6 69.1361.94 12 NP15.1813.66 11 50.8344.97 13 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Amrutanjan Health Care recommends final dividend
Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 15 May 2025, inter alia, have recommended the final dividend of Rs 2.6 per equity Share (i.e. 260%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Amrutanjan Health Care to announce Quarterly Result
Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 15 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Amrutanjan Health Care standalone net profit rises 10.32% in the December 2024 quarter
Net profit of Amrutanjan Health Care rose 10.32% to Rs 19.25 crore in the quarter ended December 2024 as against Rs 17.45 crore during the previous quarter ended December 2023. Sales rose 4.92% to Rs 122.75 crore in the quarter ended December 2024 as against Rs 116.99 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales122.75116.99 5 OPM %19.0218.45 - PBDT27.6525.29 9 PBT25.9923.71 10 NP19.2517.45 10 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Board of Amrutanjan Health Care recommends Second Interim dividend
Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 12 February 2025, inter alia, have recommended the Second Interim dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Amrutanjan Health Care schedules board meeting
Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Board of Amrutanjan Health Care recommends first interim dividend
Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 12 November 2024, inter alia, have recommended the first interim dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Amrutanjan Health Care standalone net profit rises 72.26% in the September 2024 quarter
Net profit of Amrutanjan Health Care rose 72.26% to Rs 11.80 crore in the quarter ended September 2024 as against Rs 6.85 crore during the previous quarter ended September 2023. Sales rose 10.68% to Rs 109.92 crore in the quarter ended September 2024 as against Rs 99.31 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales109.9299.31 11 OPM %12.376.89 - PBDT17.5910.76 63 PBT15.949.21 73 NP11.806.85 72 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Amrutanjan Health Care to convene board meeting
Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Amrutanjan Health Care to conduct AGM
Amrutanjan Health Care announced that the 87th Annual General Meeting (AGM) of the company will be held on 23 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.94%, vs industry avg of 9.02%
Over the last 5 years, market share increased from 0.06% to 0.11%
Over the last 5 years, net income has grown at a yearly rate of 12.89%, vs industry avg of 15.29%